GranuLab (M) Sdn. Bhd. (formerly known as Supreme Headline Sdn. Bhd.) was established in May 2005 and is a subsidiary of Sindora Berhad (Member of Johor Corporation). GranuLab has been granted by SIRIM Berhad the sole licensing to commercialise GranuMas™, a granular synthetic bone graft material and has embarked upon the setting up of medical grade plant for the production of GranuMas™.

GranuLab (M) Sdn. Bhd. has been granted the commercialization of granular synthetic bone graft material, GranuMas™ by SIRIM Bhd. It subsidiary of Sindora Bhd (Member of Johor Corporation), GranuLab has embarked upon the setting up of medical grade plant for the production of GranuMas™. GranuLab is lead by En. Romli Ishak as Managing Director.

	To establish the nation first medical grade production plant for synthetic bone graft.
	To promote Malaysia as a centre for healthcare biotechnology through research and development, innovation, and commercialisation.